pharma · Nonalcoholic Steatohepatitis (NASH) · Amyotrophic Lateral Sclerosis · CORT
CORCEPT THERAPEUTICS
CORCEPT THERAPEUTICS INC
Corcept Therapeutics is a pharma organization headquartered in Redwood City, USA. It trades on NYSE under ticker CORT. Primary therapeutic focus areas include Nonalcoholic Steatohepatitis (NASH), Amyotrophic Lateral Scle
101 Redwood Shores Pkwy, Redwood City, California 94065, US HQ
1998 Founded
756 Employees
Public company Type
CORT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 101 Redwood Shores Pkwy, Redwood City, California 94065, US
- Founded
- 1998
- Employees
- 756
- Programs
- 67
- Drugs
- 36
- Patents
- 120
Relacorilant, 100 mg and 25 mg
Phase 3 · small molecule · Metastatic Pancreatic Ductal Adenocarcinoma
Relacorilant, 100 mg and 25 mg for Metastatic Pancreatic Ductal Adenocarcinoma is a Phase 3 program (small_molecule) at CORCEPT THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Internal code CORT125134-553
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- CORCEPT THERAPEUTICS INC
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- terminated
- Trials
- 1